• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球白血病负担、风险因素分析及 1990 年至 2030 年的预测研究。

Global burden, risk factor analysis, and prediction study of leukaemia from 1990 to 2030.

机构信息

Department of Haematology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Zhoukou Central Hospital, Zhoukou, China.

出版信息

J Glob Health. 2024 Aug 23;14:04150. doi: 10.7189/jogh.14.04150.

DOI:10.7189/jogh.14.04150
PMID:39173170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11345035/
Abstract

BACKGROUND

Leukaemia is a devastating disease with an incidence that progressively increases with advancing age. The World Health Organization has designated 2021-30 as the decade of healthy ageing, highlighting the need to address age-related diseases. We estimated the disease burden of leukaemia and forecasted it by 2030.

METHODS

Based on the Global Burden of Disease 2019 database, we systematically analysed the geographical distribution of leukaemia and its subtypes. We used Joinpoint regression and Bayesian age-period-cohort models to evaluate incidence and mortality trends from 1990 to 2019 and projections through 2030. We analysed five leukaemia subtypes and the impact of age, gender, and social development. Decomposition analysis revealed the effects of disease burden on ageing and population growth. We used frontier analysis to illustrate the potential of each country to reduce its burden based on its development levels.

RESULTS

Globally, the absolute numbers of leukaemia incidence and mortality have increased, while the age-standardised rates (ASRs) have shown a decreasing trend. The disease burden was more pronounced in men, the elderly, and regions with a high socio-demographic index (SDI), where ageing and population growth played varying roles across subtypes. From 2000 to 2006, disease burdens were most effectively controlled. Global ASRs of incidence might stabilise, while ASRs of death are expected to decrease until 2030. Frontier analysis showed that middle and high-middle SDI countries have the most improvement potential. Smoking and high body mass index were the main risk factors for leukaemia-related mortality and disability-adjusted life years.

CONCLUSIONS

The absolute number of leukaemia cases has increased worldwide, but there has been a sharp decline in ASRs over the past decade, primarily driven by population growth and ageing. Countries with middle and high-middle SDI urgently need to take action to address this challenge.

摘要

背景

白血病是一种毁灭性疾病,其发病率随着年龄的增长而逐渐增加。世界卫生组织已将 2021-2030 年指定为健康老龄化十年,强调需要解决与年龄相关的疾病。我们估算了白血病的疾病负担,并对 2030 年的情况进行了预测。

方法

我们基于 2019 年全球疾病负担数据库,系统地分析了白血病及其亚型的地理分布。我们使用 Joinpoint 回归和贝叶斯年龄-时期-队列模型,评估了 1990 年至 2019 年的发病率和死亡率趋势,并对 2030 年的情况进行了预测。我们分析了五种白血病亚型以及年龄、性别和社会发展的影响。分解分析揭示了疾病负担对人口老龄化和人口增长的影响。我们使用前沿分析来说明每个国家根据其发展水平降低疾病负担的潜力。

结果

全球范围内,白血病发病率和死亡率的绝对值有所增加,而年龄标准化率(ASR)呈下降趋势。该疾病的负担在男性、老年人和社会人口指数(SDI)较高的地区更为严重,在这些地区,各亚型的疾病负担受到人口老龄化和人口增长的不同影响。从 2000 年到 2006 年,疾病负担的控制效果最为显著。全球发病率的 ASR 可能会稳定,而死亡率的 ASR 预计将在 2030 年之前下降。前沿分析表明,中高 SDI 国家具有最大的改善潜力。吸烟和高身体质量指数是白血病相关死亡率和伤残调整生命年的主要危险因素。

结论

全球白血病病例的绝对数量有所增加,但过去十年中 ASR 急剧下降,主要原因是人口增长和人口老龄化。中高 SDI 国家迫切需要采取行动应对这一挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/302cd20e5575/jogh-14-04150-F8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/8671c994f914/jogh-14-04150-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/6eed0897f4e0/jogh-14-04150-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/0b797a7700f5/jogh-14-04150-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/827bd3f1cd32/jogh-14-04150-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/652c764a65a5/jogh-14-04150-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/7627d9d0cada/jogh-14-04150-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/07f5d4f01746/jogh-14-04150-F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/302cd20e5575/jogh-14-04150-F8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/8671c994f914/jogh-14-04150-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/6eed0897f4e0/jogh-14-04150-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/0b797a7700f5/jogh-14-04150-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/827bd3f1cd32/jogh-14-04150-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/652c764a65a5/jogh-14-04150-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/7627d9d0cada/jogh-14-04150-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/07f5d4f01746/jogh-14-04150-F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f795/11345035/302cd20e5575/jogh-14-04150-F8.jpg

相似文献

1
Global burden, risk factor analysis, and prediction study of leukaemia from 1990 to 2030.全球白血病负担、风险因素分析及 1990 年至 2030 年的预测研究。
J Glob Health. 2024 Aug 23;14:04150. doi: 10.7189/jogh.14.04150.
2
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家 84 种行为、环境、职业和代谢风险以及 195 个国家和地区 1990 至 2017 年风险簇的比较风险评估:全球疾病负担研究 2017 系统分析。
Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
3
Disease burden of AIDS in last 30-year period and its predicted level in next 25-years based on the global burden disease 2019.基于 2019 年全球疾病负担研究,预测未来 25 年艾滋病的疾病负担及其预测水平。
BMC Public Health. 2024 Sep 2;24(1):2384. doi: 10.1186/s12889-024-19934-4.
4
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
5
Global, regional, and national burden and trends of air pollution-related neoplasms from 1990 to 2019: An observational trend study from the Global Burden of Disease Study 2019.全球、区域和国家 1990 年至 2019 年与空气污染相关的肿瘤负担和趋势:2019 年全球疾病负担研究的观察性趋势研究。
Ecotoxicol Environ Saf. 2024 Oct 15;285:117068. doi: 10.1016/j.ecoenv.2024.117068. Epub 2024 Sep 24.
6
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
7
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家发病率、患病率以及 195 个国家和地区 1990 年至 2016 年 328 种疾病和伤害导致的残疾年数:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
8
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021.全球、地区和国家的真菌性皮肤病负担:204 个国家和地区 1990 年至 2021 年的疾病负担分析:2021 年全球疾病负担研究。
Mycoses. 2024 Aug;67(8):e13787. doi: 10.1111/myc.13787.
9
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.全球 195 个国家和地区 1990 年至 2017 年急性髓系白血病的全球负担和归因风险因素分析:基于 2017 年全球疾病负担研究的估计。
J Hematol Oncol. 2020 Jun 8;13(1):72. doi: 10.1186/s13045-020-00908-z.
10
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家 5 岁以下儿童死亡率、成人死亡率、特定年龄死亡率和预期寿命,1970-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0.

引用本文的文献

1
Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990-2036: cross-national health inequalities and predictive analytics.1990 - 2036年全球、区域和国家不明原因癫痫的发病率和死亡率:跨国健康不平等与预测分析
Front Neurol. 2025 Jun 30;16:1526984. doi: 10.3389/fneur.2025.1526984. eCollection 2025.

本文引用的文献

1
Dysregulation of immunity by cigarette smoking promotes inflammation and cancer: A review.吸烟引起的免疫失调促进炎症和癌症:综述。
Environ Pollut. 2023 Dec 15;339:122730. doi: 10.1016/j.envpol.2023.122730. Epub 2023 Oct 12.
2
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.归因于风险因素的癌症全球负担,2010-19 年:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Aug 20;400(10352):563-591. doi: 10.1016/S0140-6736(22)01438-6.
3
DNA damage, DNA repair and carcinogenicity: Tobacco smoke versus electronic cigarette aerosol.
DNA 损伤、DNA 修复与致癌性:烟草烟雾与电子烟气溶胶的对比。
Mutat Res Rev Mutat Res. 2022 Jan-Jun;789:108409. doi: 10.1016/j.mrrev.2021.108409. Epub 2021 Dec 20.
4
Clonal dynamics of haematopoiesis across the human lifespan.人类生命全程中的造血克隆动力学。
Nature. 2022 Jun;606(7913):343-350. doi: 10.1038/s41586-022-04786-y. Epub 2022 Jun 1.
5
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家 204 个地区 1990-2019 年 12 种精神障碍疾病的负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10.
6
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.2010 年至 2019 年 29 种癌症的发病率、死亡率、生命损失年数、失能生存年数和伤残调整生命年:2019 年全球疾病负担研究的系统分析。
JAMA Oncol. 2022 Mar 1;8(3):420-444. doi: 10.1001/jamaoncol.2021.6987.
7
Influence of Benzo(a)pyrene on Different Epigenetic Processes.苯并(a)芘对不同表观遗传过程的影响。
Int J Mol Sci. 2021 Dec 15;22(24):13453. doi: 10.3390/ijms222413453.
8
Global, Regional, and National Burden of Ischemic Stroke, 1990-2019.全球、区域和国家缺血性脑卒中负担,1990-2019 年。
Neurology. 2022 Jan 18;98(3):e279-e290. doi: 10.1212/WNL.0000000000013115. Epub 2021 Dec 15.
9
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.2019年青少年和青年癌症的全球负担:全球疾病负担研究2019的系统分析
Lancet Oncol. 2022 Jan;23(1):27-52. doi: 10.1016/S1470-2045(21)00581-7. Epub 2021 Dec 3.
10
Which Tyrosine Kinase Inhibitors Should Be Selected as the First-Line Treatment for Chronic Myelogenous Leukemia in Chronic Phase?哪种酪氨酸激酶抑制剂应被选作慢性期慢性髓性白血病的一线治疗药物?
Cancers (Basel). 2021 Oct 12;13(20):5116. doi: 10.3390/cancers13205116.